Effects of hormone replacement therapy on clinical fractures and height loss: the heart and estrogen/progestin replacement study (HERS)
- 1 April 2001
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 110 (6) , 442-450
- https://doi.org/10.1016/s0002-9343(01)00647-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- A Four-Year Randomized Controlled Trial of Hormone Replacement and Bisphosphonate, Alone or in Combination, in Women with Postmenopausal OsteoporosisThe American Journal of Medicine, 1998
- Events per person year--a dubious conceptBMJ, 1995
- Estrogen Replacement Therapy and Fractures in Older WomenAnnals of Internal Medicine, 1995
- Fracture protection provided by long-term estrogen treatmentOsteoporosis International, 1995
- Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal WomenAnnals of Internal Medicine, 1992
- Treatment of Postmenopausal Osteoporosis with Transdermal EstrogenAnnals of Internal Medicine, 1992
- Prevalence and determinants of estrogen replacement therapy in elderly womenAmerican Journal of Obstetrics and Gynecology, 1990
- Hormone Replacement Therapy and the Risk for First Hip FractureAnnals of Internal Medicine, 1990
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980
- PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMENThe Lancet, 1980